Barely Significant
← all excerpts

Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis.

Aliment Pharmacol Ther · 2019 · PMC6593792 · PMID 30895635

Europe PMCDOI
1
hedged sentence
0.0990
closest p · 2.0× alpha
0.0990
boldest claim

The sentences

did not reach statistical significanceP = 0.099so close (0.05 < p ≤ 0.1)
The overall test for difference in adjusted mean 5‐ASA concentration (averaged over location) between the three 5‐ASA formulation groups (Table 2 ) did not reach statistical significance ( P = 0.099), but pairwise comparisons revealed a significant higher mean concentration in patients using Mezavant compared with Pentasa (geometric mean 2.39 ng/mg vs 0.57 ng/mg, P = 0.033) and a nonsignificant higher mean value compared to the Asacol group (2.39 ng/mg vs 1.60 ng/mg, P = 0.50).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.